Bruker Shares Fall on Convertible Share Offering Aimed at Debt Repayment
By Katherine Hamilton
Bruker shares fell after the company said it was initiating a public offering of $600 million convertible preferred shares.
The stock fell 8.5% to $30.40 in after-hours trading Tuesday. At the close, shares were down 43% this year.
The offering includes 2.4 million shares in aggregate, the scientific instruments maker said Tuesday.
The Billerica, Mass. company intends to use the net proceeds to repay its term loan due in December 2026, as well as outstanding borrowing under a revolving credit agreement and a portion of its term loan due in March 2027.
Bruker plans to grant underwriters a 30-day option to purchase up to $90 million in additional stock. If underwriters exercise that option, Bruker will use those proceeds for general purposes, which could include further debt payments.
Write to Katherine Hamilton at katherine.hamilton@wsj.com
(END) Dow Jones Newswires
September 02, 2025 18:10 ET (22:10 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Companies to Invest in Now
The 10 Best Dividend Stocks
United States